Sorex fumeus (smoky shrew): 130023746
Help
Entry
130023746 CDS
T10594
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
sfum Sorex fumeus (smoky shrew)
Pathway
sfum01524
Platinum drug resistance
sfum04010
MAPK signaling pathway
sfum04115
p53 signaling pathway
sfum04148
Efferocytosis
sfum04210
Apoptosis
sfum04215
Apoptosis - multiple species
sfum04623
Cytosolic DNA-sensing pathway
sfum04650
Natural killer cell mediated cytotoxicity
sfum04657
IL-17 signaling pathway
sfum04668
TNF signaling pathway
sfum04726
Serotonergic synapse
sfum04932
Non-alcoholic fatty liver disease
sfum04933
AGE-RAGE signaling pathway in diabetic complications
sfum04936
Alcoholic liver disease
sfum05010
Alzheimer disease
sfum05012
Parkinson disease
sfum05014
Amyotrophic lateral sclerosis
sfum05016
Huntington disease
sfum05020
Prion disease
sfum05022
Pathways of neurodegeneration - multiple diseases
sfum05132
Salmonella infection
sfum05133
Pertussis
sfum05134
Legionellosis
sfum05145
Toxoplasmosis
sfum05146
Amoebiasis
sfum05152
Tuberculosis
sfum05160
Hepatitis C
sfum05161
Hepatitis B
sfum05162
Measles
sfum05163
Human cytomegalovirus infection
sfum05164
Influenza A
sfum05165
Human papillomavirus infection
sfum05167
Kaposi sarcoma-associated herpesvirus infection
sfum05168
Herpes simplex virus 1 infection
sfum05169
Epstein-Barr virus infection
sfum05170
Human immunodeficiency virus 1 infection
sfum05200
Pathways in cancer
sfum05203
Viral carcinogenesis
sfum05205
Proteoglycans in cancer
sfum05206
MicroRNAs in cancer
sfum05210
Colorectal cancer
sfum05222
Small cell lung cancer
sfum05416
Viral myocarditis
sfum05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
sfum00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
130023746 (CASP3)
04668 TNF signaling pathway
130023746 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
130023746 (CASP3)
09143 Cell growth and death
04210 Apoptosis
130023746 (CASP3)
04215 Apoptosis - multiple species
130023746 (CASP3)
04115 p53 signaling pathway
130023746 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
130023746 (CASP3)
04650 Natural killer cell mediated cytotoxicity
130023746 (CASP3)
04657 IL-17 signaling pathway
130023746 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
130023746 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
130023746 (CASP3)
05206 MicroRNAs in cancer
130023746 (CASP3)
05205 Proteoglycans in cancer
130023746 (CASP3)
05203 Viral carcinogenesis
130023746 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
130023746 (CASP3)
05222 Small cell lung cancer
130023746 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
130023746 (CASP3)
05161 Hepatitis B
130023746 (CASP3)
05160 Hepatitis C
130023746 (CASP3)
05164 Influenza A
130023746 (CASP3)
05162 Measles
130023746 (CASP3)
05168 Herpes simplex virus 1 infection
130023746 (CASP3)
05163 Human cytomegalovirus infection
130023746 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
130023746 (CASP3)
05169 Epstein-Barr virus infection
130023746 (CASP3)
05165 Human papillomavirus infection
130023746 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
130023746 (CASP3)
05133 Pertussis
130023746 (CASP3)
05134 Legionellosis
130023746 (CASP3)
05152 Tuberculosis
130023746 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
130023746 (CASP3)
05145 Toxoplasmosis
130023746 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
130023746 (CASP3)
05012 Parkinson disease
130023746 (CASP3)
05014 Amyotrophic lateral sclerosis
130023746 (CASP3)
05016 Huntington disease
130023746 (CASP3)
05020 Prion disease
130023746 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
130023746 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
130023746 (CASP3)
05416 Viral myocarditis
130023746 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
130023746 (CASP3)
04932 Non-alcoholic fatty liver disease
130023746 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
130023746 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
130023746 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
sfum01002
]
130023746 (CASP3)
Enzymes [BR:
sfum01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
130023746 (CASP3)
Peptidases and inhibitors [BR:
sfum01002
]
Cysteine peptidases
Family C14: caspase family
130023746 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Erf4
Motif
Other DBs
NCBI-GeneID:
130023746
NCBI-ProteinID:
XP_055970312
LinkDB
All DBs
Position
Unknown
AA seq
276 aa
AA seq
DB search
MENSEISVDAKSVKNSEEKIIHGSKSVDSGISLDNSYKMNYPEMGVCLIINNKNFKGEGM
STRTGTDVDAARLKETFTNLKYEVRIKNDLTCEEIKKLLYSASLEDHSKRSSFICVFLSH
GEEGTIFGTDKPIELKILAGFFKGDCCRSLTGKPKIFIIQACRGTELDCGIETDSGSEDD
MTCQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCEILKRYADKLEFMHILTRVNQ
KVATEFESYSLDRTFHAKKQIPCIMSMLTKELYFYH
NT seq
831 nt
NT seq
+upstream
nt +downstream
nt
atggagaactctgaaatctcagtagacgcaaaatccgtaaagaattcagaagaaaagatc
atacatggcagcaagtcagtggactctggaatatcgttggacaatagttacaaaatgaat
tatcctgaaatgggcgtgtgtttaataattaataataagaacttcaaaggcgaaggcatg
tcgactcggaccggtacagatgtagatgcagcaagactcaaggaaacgtttactaacttg
aaatacgaagtcaggatcaaaaatgatctgacctgtgaggaaattaagaaattgctgtac
agtgcttctttagaagatcatagcaaaaggagcagttttatttgtgtgtttctaagccat
ggtgaagaaggaaccatttttggaacagataaacctattgagctgaagatcttagcaggt
ttcttcaaaggggattgttgcagaagtctaactggaaaacccaaaattttcattattcag
gcctgccgaggtacagaactcgactgtggaatagagactgacagtggttctgaggatgac
atgacgtgtcagaagataccagtggaagctgacttcttgtatgcgtattccacagcacct
ggttactattcttggcgcaattcaaaggatggatcctggttcattcagtcactttgtgag
atattgaagcggtacgctgacaaacttgagttcatgcacattcttactcgggtcaaccaa
aaggtagcaacagaatttgagtcctattccttggacagaactttccacgcaaagaagcag
attccatgtattatgtctatgctcacaaaagaactgtatttttatcactga
DBGET
integrated database retrieval system